Adial Pharmaceuticals Inc

NASDAQ:ADIL

2.78

+0.20 (+7.75%)

7:55:22 PM EDT: $2.70 -0.08 (-2.87%)

Adial Pharmaceuticals Inc Stock, NASDAQ:ADIL

1180 Seminole Trail, Suite 495, Charlottesville, Virginia 22901

United States of America

Phone: +1.434.422.9800

Number of Employees: 20

http://www.adialpharma.com

Description

Adial Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company, which focuses on the treatment of alcohol use disorder. Its lead product is AD04, a selective serotonin-3 antagonist. The company was founded by Bankole A. Johnson & William B. Stilley in November 2010 and is headquartered in Charlottesville, VA.